The global percutaneous skin patch market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The percutaneous patch is a method for drug delivery that works by sticking to the skin. Also known by the name as transdermal, these patches have medicinal ingredients on their surface which are absorbed through the skin and later channelized into the bloodstream. As intended, this patch improvises the drug delivery path through a predetermined dose of medication. The primary factor attributed to spur the market growth includes the growing regulatory approvals by various authorities as a positive measure to improve public health. For instance, in September 2021, Luye Pharma announced that it has received approval for Rivastigmine Multi-Day Transdermal Patch for treating mild to moderate dementia associated with Alzheimer’s disease by the UK’s Medicines and Healthcare Products Regulatory Agency. Such approvals are likely to boost the global percutaneous skin patch market.
To Request a Sample of our Report on Percutaneous Skin Patch Market: https://www.omrglobal.com/request-sample/percutaneous-skin-patch-market
Another key trend attributed to the rising demand for these skin patches includes the product innovation and enhancements that further raise patient adherence to their recommended therapeutics. For instance, in September 2021, ImQuest Biosciences has announced the launch of an antiretroviral (ARV) transdermal delivery patch. This patch was introduced as a substitute for oral medication for HIV patients. In addition to this, in December 2020, Agile Therapeutics Inc. announced the launch of Twirla (Levonorgestrel and Ethinyl Estradiol) transdermal system, a new non-daily, non-invasive contraceptive patch, in the US. It is launched for women of reproductive potential who have a Body Mass Index (BMI) <30 kg/m2 for whom a combined hormonal contraceptive is appropriate to prevent pregnancy.
Market Coverage
- The market number available for – 2021-2027
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Teva Pharmaceutical Industries Ltd., Novartis International AG, and Mylan NV, among others.
(Get 15% Discount on Buying this Report)
A full Report of Percutaneous Skin Patch Market is Available @ https://www.omrglobal.com/industry-reports/percutaneous-skin-patch-market
Global Percutaneous Skin Patch Market Report by Segment
By Type
- Single-Layer Drug-in-Adhesive
- Multi-Layer Drug-in-Adhesive
- Others
By Application
- Neurologic Conditions
- Pain Management
- Nicotine Cessation
- Others
Global Percutaneous Skin Patch Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
